Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
markets
Globalisation declining? Not in investor portfolios
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,206.10 | 72.70 | 0.89% |
| CAC 40 | 7,724.32 | 97.19 | 1.27% |
| DAX 40 | 18,748.18 | 213.62 | 1.15% |
| Dow JONES (US) | 40,000.90 | 247.15 | 0.62% |
| FTSE 100 | 8,252.91 | 29.57 | 0.36% |
| HKSE | 18,293.38 | 461.05 | 2.59% |
| NASDAQ | 18,398.45 | 115.04 | 0.63% |
| Nikkei 225 | 41,190.68 | 1,033.34 | -2.45% |
| NZX 50 Index | 12,134.97 | 76.68 | 0.64% |
| S&P 500 | 5,615.35 | 30.81 | 0.55% |
| S&P/ASX 200 | 7,959.30 | 69.70 | 0.88% |
| SSE Composite Index | 2,971.29 | 0.91 | 0.03% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 3.03% |
| Core Lithium Ltd CXO | 0.11 | 0.01 | 10.00% |
| Red 5 Ltd RED | 0.43 | 0.01 | 1.19% |
| Imugene Ltd IMU | 0.06 | 0.01 | 9.26% |
| Telstra Group Ltd TLS | 3.82 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 2.34 | 0.16 | 7.34% |
| Mirvac Group MGR | 2.01 | 0.08 | 4.15% |
| Latin Resources Ltd LRS | 0.17 | 0.00 | 0.00% |
| Melbana Energy Ltd MAY | 0.02 | 0.00 | -4.35% |
| Botanix Pharmaceuticals Ltd BOT | 0.38 | 0.06 | 16.92% |